发明授权
US08614321B2 Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
失效
用于炎症和免疫相关用途的苯并咪唑基吡嗪化合物
- 专利标题： Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
- 专利标题（中）： 用于炎症和免疫相关用途的苯并咪唑基吡嗪化合物
-
申请号： US13353713申请日： 2012-01-19
-
公开(公告)号： US08614321B2公开(公告)日： 2013-12-24
- 发明人: Shoujun Chen , Jun Jiang , Junyi Zhang , Yu Xie
- 申请人： Shoujun Chen , Jun Jiang , Junyi Zhang , Yu Xie
- 申请人地址： US MA Lexington
- 专利权人： Synta Pharmaceuticals Corp.
- 当前专利权人： Synta Pharmaceuticals Corp.
- 当前专利权人地址： US MA Lexington
- 代理机构： Wolf, Greenfield & Sacks, P.C.
- 主分类号： C07D461/00
- IPC分类号： C07D461/00
摘要：
The invention relates to compounds of structural formula (I) or (III): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein ring A, X1, X2, X3, X5, R1, R4, Y, Z, L, m and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
公开/授权文献
信息查询
